Scilex Holding Company

07/22/2026 | Press release | Distributed by Public on 07/22/2026 15:31

Material Agreement, Asset Transaction (Form 8-K)

Item 1.01. Entry into a Material Definitive Agreement.

On July 18, 2026, Scilex Holding Company (the "Company") entered into a stock repurchase agreement (the "Vivasor Repurchase Agreement") with Vivasor Holding Company ("Vivasor"), pursuant to which the Company agreed to sell to Vivasor (i) 6,101,468 shares of Vivasor's Series A-1 Preferred Stock, par value $0.00001 per share, and (ii) 355,919 shares of Vivasor's Series A-2 Preferred Stock, par value $0.00001 per share, in each case which had been previously acquired by the Company in January 2026 (such previously acquired shares, collectively, the "Subject Shares").

Vivasor will purchase the Subject Shares from the Company for an aggregate purchase price of $11,999,762.28 payable by wire transfer, by assignment of the shares of common stock of Datavault AI, Inc. held by Vivasor, Inc., a subsidiary of Vivasor, or by any combination of such methods (the "Purchase Price"). The Vivasor Repurchase Agreement provides that the Purchase Price will be paid in tranches as follows: (i) $999,980.97 on July 18, 2026; (ii) $4,999,901.10 at any time on or before September 30, 2026; (iii) $1,999,960.07 at any time after September 30, 2026 but on or before December 31, 2026; (iv) $1,999,960.07 at any time after December 31, 2026 but on or before March 31, 2027; and (v) $1,999,960.07 at any time after March 31, 2027 but on or before June 30, 2027.

The Vivasor Repurchase Agreement contains customary representations, warranties, covenants, indemnification provisions and other terms typical for transactions of this nature.

Dr. Henry Ji, Ph.D., the Company's current Chief Executive Officer, President and Chairperson, currently serves as the Chief Executive Officer of Vivasor.

The foregoing description of the Vivasor Repurchase Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Vivasor Repurchase Agreement, a copy of which is attached hereto as Exhibit 10.1 and is incorporated by reference herein.

Item 2.01. Completion of Acquisition or Disposition of Assets.

The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.

Scilex Holding Company published this content on July 22, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on July 22, 2026 at 21:31 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]